Identifying common transcriptome signatures of cancer by interpreting deep learning models

Abstract

Background Cancer is a set of diseases characterized by unchecked cell proliferation and invasion of surrounding tissues. The many genes that have been genetically associated with cancer or shown to directly contribute to oncogenesis vary widely between tumor types, but common gene signatures that relate to core cancer pathways have also been identified. It is not clear, however, whether there exist additional sets of genes or transcriptomic features that are less well known in cancer biology but that are also commonly deregulated across several cancer types. Results Here, we agnostically identify transcriptomic features that are commonly shared between cancer types using 13,461 RNA-seq samples from 19 normal tissue types and 18 solid tumor types to train three feed-forward neural networks, based either on protein-coding gene expression, lncRNA expression, or splice junction use, to distinguish between normal and tumor samples. All three models recognize transcriptome signatures that are consistent across tumors. Analysis of attribution values extracted from our models reveals that genes that are commonly altered in cancer by expression or splicing variations are under strong evolutionary and selective constraints. Importantly, we find that genes composing our cancer transcriptome signatures are not frequently affected by mutations or genomic alterations and that their functions differ widely from the genes genetically associated with cancer. Conclusions Our results highlighted that deregulation of RNA-processing genes and aberrant splicing are pervasive features on which core cancer pathways might converge across a large array of solid tumor types.

KBPRNA: A novel method integrating bulk RNA-seq data and LINCS-L1000 gene signatures to predict kinase activity based on machine learning

“…Then scanpy was utilized to cluster several cell groups from scRNA-seq datasets of breast cancer tissues. Our results show similar clustering performance compared to that when using real scRNA-seq datasets [29].…”

Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma

“…In fact, the transcriptome can help decipher the true configuration of the inner network of cancer cells much more than the simple knowledge of mutated genes; by observing the shift in gene expression, the true weight of each mutation can be inferred. In addition, transcriptomic analysis can identify another class of oncogenic drivers: those that depend not on a DNA mutation (and are, therefore, invisible to genomic profiling) but only on under-or overexpression [123].…”

Deep Learning Approaches for lncRNA-Mediated Mechanisms: A Comprehensive Review of Recent Developments

“…The second group of studies implemented GNNs to predict lncRNA–disease associations [ 35 , 36 , 38 , 39 , 40 , 41 , 46 , 47 , 50 ]. These studies demonstrated superior performance in making predictions, and were able to handle multi-view data and efficiently fuse node features, topological structures, and semantic information.…”